TAYLOR OUSLEY: Open Payments
NPI 1649899006 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,165 in 92 payments from 7 companies in 2025. Trend: 2023 $42 · 2024 $424 · 2025 $2,165
Food & beverage: $2,050Education: $115
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $494 |
| Neurocrine BioSciences, Inc. | 17 | $493 |
| Teva Pharmaceuticals USA, Inc. | 16 | $416 |
| Alkermes, Inc. | 12 | $363 |
| Otsuka America Pharmaceutical, Inc. | 17 | $308 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $41 |
Products named: COBENFY, INGREZZA, UZEDY, ARISTADA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, LYBALVI, FANAPT.
Industry payments across AL — which companies pay providers there.
